Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer's patches after vertical transmission
- PMID: 36245510
- PMCID: PMC9554658
- DOI: 10.3389/fnut.2022.987400
Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer's patches after vertical transmission
Abstract
Objectives: Limosilactobacillus reuteri FN041 is a potential probiotic bacterium isolated from breast milk in traditional farming and pastoral areas of China. The purpose of this study was to investigate the optimal intervention mode and potential mechanism of FN041 to prevent atopic dermatitis (AD) in mice.
Methods: In intervention mode I, FN041 was supplemented to dams during the late trimester and lactation and pups after weaning; in intervention mode II, FN041 was supplemented after pups were weaned. AD was induced in pups with MC903 plus ovalbumin on the ear after weaning.
Results: The effect of intervention mode I in preventing AD was significantly better than that of intervention mode II. Compared with the model group, the inflammatory response of the pup's ears, the proportion of spleen regulatory T cells and the plasma IgE were significantly decreased in mice in intervention mode I. Furthermore, the intestinal mucosal barrier was enhanced, and the Shannon index of the ileal microbiota was significantly increased. The microbiota structure deviated from the AD controls and shifted toward the healthy controls according to the PCoA of unweighted UniFrac. The relative abundances of Limosilactobacillus, Faecalibacterium, Bifidobacterium, and Akkermansia in the ileum were significantly increased compared to the AD group. Based on RNA-seq analysis of pups' Peyer's patches (PPs), FN041 inhibits autoimmune pathways such as asthma and systemic lupus erythematosus and activates retinol metabolism and PPAR signaling pathways to reduce inflammatory responses. Intervention mode II also significantly reduced AD severity score, but the reduction was approximately 67% of that of intervention mode I. This may be related to its ineffective remodeling of the ileal microbiota.
Conclusion: Prenatal and postnatal administration of FN041 is an effective way to prevent AD in offspring, and its mechanism is related to remodeling of ileal microbiota and PPs immune response.
Keywords: Limosilactobacillus reuteri; Peyer’s patches; atopic dermatitis; ileal mucosal barrier; regulatory T cells; retinol metabolism; vertical transmission.
Copyright © 2022 Zhou, Xu, Li, Tu, Li, Chang, Chen, Yu, Qi and Sun.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures









Similar articles
-
Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications.Front Immunol. 2023 Aug 9;14:1228754. doi: 10.3389/fimmu.2023.1228754. eCollection 2023. Front Immunol. 2023. PMID: 37638038 Free PMC article. Review.
-
Breast Milk-Derived Limosilactobacillus reuteri Prevents Atopic Dermatitis in Mice via Activating Retinol Absorption and Metabolism in Peyer's Patches.Mol Nutr Food Res. 2023 Jan;67(2):e2200444. doi: 10.1002/mnfr.202200444. Epub 2022 Dec 8. Mol Nutr Food Res. 2023. PMID: 36480309
-
Maternal supplementation with Limosilactobacillus reuteri FN041 for preventing infants with atopic dermatitis: study protocol for a randomized controlled trial.Front Microbiol. 2023 Oct 5;14:1267448. doi: 10.3389/fmicb.2023.1267448. eCollection 2023. Front Microbiol. 2023. PMID: 37869669 Free PMC article.
-
Prevention of Atopic Dermatitis in Mice by Lactobacillus Reuteri Fn041 Through Induction of Regulatory T Cells and Modulation of the Gut Microbiota.Mol Nutr Food Res. 2022 Mar;66(6):e2100699. doi: 10.1002/mnfr.202100699. Epub 2022 Jan 23. Mol Nutr Food Res. 2022. PMID: 34825773
-
The intestinal habitat for organized lymphoid tissues in ruminants; comparative aspects of structure, function and development.Vet Immunol Immunopathol. 1991 Mar;28(1):1-16. doi: 10.1016/0165-2427(91)90038-e. Vet Immunol Immunopathol. 1991. PMID: 1905075 Review.
Cited by
-
Lactobacillus for the treatment and prevention of atopic dermatitis: Clinical and experimental evidence.Front Cell Infect Microbiol. 2023 Feb 16;13:1137275. doi: 10.3389/fcimb.2023.1137275. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36875529 Free PMC article. Review.
-
Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications.Front Immunol. 2023 Aug 9;14:1228754. doi: 10.3389/fimmu.2023.1228754. eCollection 2023. Front Immunol. 2023. PMID: 37638038 Free PMC article. Review.
-
Atopic dermatitis and food allergy: More than sensitization.Mucosal Immunol. 2024 Oct;17(5):1128-1140. doi: 10.1016/j.mucimm.2024.06.005. Epub 2024 Jun 19. Mucosal Immunol. 2024. PMID: 38906220 Review.
-
Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists.Front Allergy. 2023 Mar 27;4:1167800. doi: 10.3389/falgy.2023.1167800. eCollection 2023. Front Allergy. 2023. PMID: 37051264 Free PMC article. Review.
-
Microbial Community and Metabolome Analysis of the Porcine Intestinal Damage Model Induced by the IPEC-J2 Cell Culture-Adapted Porcine Deltacoronavirus (PDCoV) Infection.Microorganisms. 2024 Apr 27;12(5):874. doi: 10.3390/microorganisms12050874. Microorganisms. 2024. PMID: 38792704 Free PMC article.
References
LinkOut - more resources
Full Text Sources